LRN and Nordic Business Ethics Initiative to collaborate with the 2023 survey
30.8.2023 10:00:00 EEST | Business Wire | Press release
LRN Corporation, the leader in ethics and compliance solutions that enable organizations to inspire principled performance, today announces a collaboration with the Nordic Business Initiative (NBE) to deliver deeper insights into ethics and compliance (E&C) issues across the Nordic region.
LRN will be the exclusive provider of global E&C benchmarking data to NBE, which will give additional global context to the organization’s bi-annual ‘Nordic Ethics & Compliance Survey’ for the first time.
Nordic Ethics & Compliance Survey reports on trends in the state of ethics & compliance programs in the Nordic region. It analyzes data relating to internal Ethics & Compliance work in Nordic organisations. The survey responses are gathered from Denmark, Finland, Norway and Sweden.
LRN is an authoritative voice on global E&C issues and will provide key data insights and benchmarking from its world-leading 2023 Program Effectiveness Report, as well as previously unpublished insights from its full data set. The report is based on responses from more than 1,850 E&C professionals at organizations across 26 industries and in 10 different countries – the largest and most comprehensive research of its kind.
In addition to providing this extra global perspective to the NBE survey, experts from LRN will also be taking part in an event series alongside prominent speakers from NBE and other leading regional ethics and compliance experts examining the survey findings and exploring key themes and topical issues. The event series will take place after the publication of the full NBE report in November.
“The Nordic Business Ethics Initiative is doing vital work in building awareness of ethics and compliance across the Nordic region, and its research is a critical tool when it comes to understanding the state of play so that key issues can be addressed,” said Kevin Michielsen, CEO of LRN. “Our collaboration with NBE will give this important study a valuable extra dimension. For businesses across the Nordic region, including Nordic-based multi-national companies, it’s important to consider ethics and compliance issues against the global backdrop that takes account of geo-political developments, emerging challenges, and ongoing crises. The incorporation of our global data will help benchmark the performance of companies in the Nordics against their peers around the world and enable even better understanding the impact and efficacy of E&C programs.”
NBE co-founder Niina Ratsula added, “Being able to incorporate insights from LRN’s market-leading dataset into our 2023 Nordic Ethics & Compliance Survey report will give it, and our NBE members, even more value. By putting our findings around what’s happening in the Nordic region into the bigger, international picture, our research will have deeper meaning, so that organizations can see not just how the issues are developing around them, but what’s happening further afield too.”
Companies across the Nordic region are encouraged to participate in this year’s NBE survey by visiting: https://www.nordicbusinessethics.com/nordic-ethics-compliance-survey-2023/.
ENDS
Notes to Editors:
About LRN
LRN's mission and purpose is to inspire principled performance and help people around the world do the right thing. Since 1994, LRN has worked to propel organizations forward with the partnership, knowledge, and tools to build ethical culture. More than 2,800 companies and tens of millions of learners worldwide utilize LRN services and take LRN e-learning courses to help navigate complex regulatory environments and foster ethical, responsible, and inclusive cultures. In partnership with LRN, companies translate their values into concrete corporate practices and leadership behaviors that create sustainable competitive advantage. By acting upon shared values, companies and their people find the means to outbehave and outperform. Learn more at LRN.com and follow on Twitter, LinkedIn, and Facebook.
About the Nordic Business Ethics Initiative
The Nordic Business Ethics Initiative was created to build stronger and more responsible organizations. Its ambition is to promote responsible business conduct and support business leaders and professionals through sharing lessons learned, building best practices and facilitating dialogue and networking. The initiative consists of various activities, all aiming to raise awareness of what business ethics is and provide tools to create ethical, compliant workplaces.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230830345702/en/
Contact information
Media
Scott Addison, Charlotte Hole and Gabriel Oben, Infinite Global (for LRN Corporation)
LRN@infiniteglobal.com
Niina Ratsula, Co-Founder of Nordic Business Ethics Initiative, niina@nordicbusinessethics.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Presents New Data on CASGEVY ® , Including First European Presentation of Data in Children Ages 5–11, at the European Hematology Association Congress and Announces Additional Global Regulatory Submissions11.6.2026 09:01:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, from pivotal studies in children ages 5–11, show that the efficacy and safety outcomes in this age group are consistent with the transformative profile established in adult and adolescent patients. These data were presented at the European Hematology Association (EHA) Congress and simultaneously published in the New England Journal of Medicine (NEJM). “The data presented at EHA and published in NEJM underscore the consistent, durable and transformative benefits CASGEVY can provide to people living with sickle cell disease or transfusion-dependent beta thalassemia from early in life,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Off
PUMA Brings NITRO™ to Football With the PUMA NITRO Lab in Los Angeles11.6.2026 09:00:00 EEST | Press release
Global sports brand PUMA today opened the PUMA NITRO™ Lab in Los Angeles, the latest chapter of its innovation platform, and company’s most significant yet, marking the global reveal of the Ultra Nitro 7 and NITRO™'s arrival in football for the first time on a football boot. Previous editions of the NITRO™ Lab in Paris, Tokyo, and London explored the future of running performance and cemented NITRO™ as the defining technology in elite running with Fast-R3. Now, with the world’s attention turning to football, Los Angeles is where that journey takes its next step, introducing the same innovation DNA that reshaped the track to the pitch, when it matters most. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260610728823/en/ Global sports brand PUMA today opened the PUMA NITRO™ Lab in Los Angeles, the latest chapter of its innovation platform, and company’s most significant yet, marking the global reveal of the Ultra Nitro 7 and N
AHS Properties Acquires Shangri-La Hotel for AED 1.1 Billion in Landmark Sheikh Zayed Road Transaction11.6.2026 09:00:00 EEST | Press release
AHS Properties today announced the acquisition of Shangri-La Hotel for AED 1.1 billion, one of the largest single-asset real estate transactions recorded in recent history. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605096792/en/ Shangri-La Hotel Exterior, Sheikh Zayed Road. (Photo: AETOSWire) Acquired from Mismak Asset Management, the transaction cements one of the most concentrated private-sector bets on Sheikh Zayed Road's next decade. The Shangri-La Hotel is a 43-floor, 200-metre tower on Sheikh Zayed Road, and was one of the first five-star hotels to open on the corridor when it was completed in 2003. The acquisition adds an iconic anchor asset to a portfolio that already includes AHS Tower, a recently sold-out Grade-A commercial development on Sheikh Zayed Road, and AHS City, the developer’s flagship master-planned, mixed-use community on the corridor with a forecast gross development value of AED 25 billion. To
Curatis Increases Revenue Growth Guidance for 202611.6.2026 08:00:00 EEST | Press release
Curatis Holding AG (SIX: CURN) increases its revenue growth guidance for the financial year 2026: the company is forecasting a revenue growth of approximately 40% in 2026, in contrast to the previous outlook of over 25%. Based on preliminary figures for the first five months of 2026, Curatis expects a significantly higher than anticipated revenue growth for 2026. This growth is driven by products that Curatis has marketed for some time, as well as by products added to its portfolio in 2025 and 2026. Under the new guidance, Curatis projects revenues of approximately CHF 15m in 2026, up from CHF 10.8m in 2025. Curatis will publish detailed financial figures for the first six months of 2026 in the half-year report on 21 September 2026. About Curatis Curatis Holding AG is a publicly listed company (CURN.SW) focused on the late stage development and commercialization of drugs for rare diseases and specialty care. Curatis has a sales portfolio of more than 40 products and a pipeline of orpha
Galderma Unveils New Global Survey Data Exploring the Evolving Expectations and Experiences of Patients and Healthcare Professionals With Anti-wrinkle Treatments11.6.2026 08:00:00 EEST | Press release
Galderma (SIX: GALD) has released findings from a landmark global survey conducted across the United States (U.S.), Brazil, the United Kingdom (UK), and China – the largest of its kind – exploring the evolving expectations and experiences of patients and HCPs with anti-wrinkle aesthetic treatments. As the dermatology category leader, this survey demonstrates Galderma’s commitment to advancing progress in this market, through robust clinical research, product performance, and practitioner support. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260610228460/en/ Anti-wrinkle treatments are among the most established procedures in aesthetic medicine and currently represent the most commonly performed nonsurgical cosmetic treatment worldwide.2 The market is set to expand further, with 85% of surveyed patients globally indicating they plan to maintain or increase their use in the future, including 97% in China and 87% in the UK.2
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
